Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

NCT00256295 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Cancer of the Head and Neck

Interventions

DRUG: Gemcitabine
DRUG: Oxaliplatin

Sponsor

Sai-Hong Ignatius Ou

Collaborators

[object Object]